Status:
COMPLETED
Effect of Thiamphenicol on EAAT2 and Other Biomarkers From Nasal Biopsied Tissue
Lead Sponsor:
Psyadon Pharma
Collaborating Sponsors:
SGS Life Sciences, a division of SGS Belgium NV
Conditions:
Healthy
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine if two-weeks of dosing with thiamphenicol is safe and is able to change the levels of certain pre-specified biomarkers in nervous tissue taken from the nasal ...
Detailed Description
Thiamphenicol has been proposed to increase the levels of the excitatory amino acid transporter 2 (EAAT2) in the nervous tissue. This study evaluated the ability of two weeks of treatment with thiamph...
Eligibility Criteria
Inclusion
- normal volunteers
Exclusion
- less than 18 years
- older than 55 years
Key Trial Info
Start Date :
July 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00958503
Start Date
July 1 2007
End Date
April 1 2008
Last Update
March 25 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SGS Research Unit - Stuivenberg
Antwerp, Belgium